Comparison of Hemodynamic Response between Patients with Systolic Heart Failure Differing in Serum Aldosterone Concentrations during and after a 6-Minute Walk Test
暂无分享,去创建一个
A. Wykrętowicz | J. Piskorski | P. Guzik | T. Krauze | J. Kaczmarek | M. Dziarmaga | A. Schneider | Aneta Nowak | J. Tarchalski | Kamila Miętkiewska-Szwacka | K. Barecka | Anna Różańska-Kirschke | Dagmara Przymuszała-Staszak | Mateusz Bryl
[1] P. Guzik,et al. Publication ethics of human studies in the light of the Declaration of Helsinki – a mini-review , 2022, Journal of Medical Science.
[2] J. Božić,et al. Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers , 2020, World journal of cardiology.
[3] P. Ponikowski,et al. Heart rate and blood pressure monitoring in heart failure , 2019, European heart journal supplements : journal of the European Society of Cardiology.
[4] P. Ponikowski,et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology , 2019, European journal of heart failure.
[5] A. Kotsia,et al. 6-minute walking test: a useful tool in the management of heart failure patients , 2019, Therapeutic advances in cardiovascular disease.
[6] G. Reed,et al. Renin Activity in Heart Failure with Reduced Systolic Function—New Insights , 2019, International journal of molecular sciences.
[7] Bruce D. Johnson,et al. Skeletal Muscle Fatigability in Heart Failure , 2019, Front. Physiol..
[8] R. Britto,et al. Safety of early performance of the six-minute walk test following acute myocardial infarction: a cross-sectional study , 2017, Brazilian journal of physical therapy.
[9] T. Marwick,et al. Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction. , 2016, Journal of the American College of Cardiology.
[10] A. Jegier,et al. Blood Pressure Response to Submaximal Exercise Test in Adults , 2016, BioMed research international.
[11] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[12] A. Wykrętowicz,et al. Prospective observational study on predicting adverse clinical outcomes in patients with implanted defibrillating devices – a study rationale, design and principal methods , 2016 .
[13] Piotr Ponikowski,et al. The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction. , 2015, European heart journal.
[14] T. Kulik. Pulmonary Hypertension Caused by Pulmonary Venous Hypertension , 2014, Pulmonary circulation.
[15] A. Coats,et al. The 'skeletal muscle hypothesis in heart failure' revised. , 2013, European heart journal.
[16] M. Hori,et al. Heart rate as a target of treatment of chronic heart failure. , 2012, Journal of cardiology.
[17] A. Durante,et al. Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis. , 2012, Current pharmaceutical design.
[18] W. Chan,et al. Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. , 2011, American heart journal.
[19] H. Inoue,et al. Renal insufficiency coexisting with heart failure is related to elevated sympathetic nerve activity , 2010, Autonomic Neuroscience.
[20] Arturo Evangelista,et al. European Association of Echocardiography recommendations for training, competence, and quality improvement in echocardiography. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[21] Javed Butler,et al. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. , 2009, Journal of the American College of Cardiology.
[22] K. Dimopoulos,et al. Cardiovascular and ventilatory control during exercise in chronic heart failure: role of muscle reflexes. , 2008, International journal of cardiology.
[23] Nancy M Albert,et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. , 2006, JAMA.
[24] A. Hinz,et al. Acute Effects of Aldosterone on the Autonomic Nervous System and the Baroreflex Function in Healthy Humans , 2006, Journal of neuroendocrinology.
[25] David J Cohen,et al. The association between blood pressure and mortality in patients with heart failure. , 2006, American heart journal.
[26] Luigi Tavazzi,et al. Acute Heart Failure Syndromes: Current State and Framework for Future Research , 2005, Circulation.
[27] ATS Statement , 2002 .
[28] ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.
[29] P. Ponikowski,et al. Enhanced Ventilatory Response to Exercise in Patients With Chronic Heart Failure and Preserved Exercise Tolerance: Marker of Abnormal Cardiorespiratory Reflex Control and Predictor of Poor Prognosis , 2001, Circulation.
[30] A. Struthers,et al. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. , 1997, Cardiovascular research.
[31] C A Beltrami,et al. Apoptosis in the failing human heart. , 1997, The New England journal of medicine.
[32] T. Thrasher. Baroreceptor Regulation of Vasopressin and Renin Secretion: Low-Pressure versus High-Pressure Receptors , 1994, Frontiers in Neuroendocrinology.
[33] S. Adamopoulos,et al. Controlled Trial of Physical Training in Chronic Heart Failure: Exercise Performance, Hemodynamics, Ventilation, and Autonomic Function , 1992, Circulation.